Specify a stock or a cryptocurrency in the search bar to get a summary
Tissue Repair Ltd
TRPTissue Repair Ltd, a clinical stage biopharmaceutical company, develops advanced wound healing products for chronic wounds and the aftercare of cosmetic procedures in Australia. It is developing TR-987, including Glucoprime technology for the treatment of chronic wounds, burns, and other complex wounds; and TR Pro+ for aftercare of minimally invasive cosmetic procedures. The company was incorporated in 2012 and is based in Sydney, Australia. Address: 255 Pitt Street, Sydney, NSW, Australia, 2000
Analytics
WallStreet Target Price
1.2 AUDP/E ratio
–Dividend Yield
–Current Year
Last Year
Current Quarter
Last Quarter
Current Year
Last Year
Current Quarter
Last Quarter
Key Figures TRP
Dividend Analytics TRP
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History TRP
Stock Valuation TRP
Financials TRP
Results | 2019 | Dynamics |